1Morita M, Kuwano H, Ohno S, et al, Ant emetic effect of ramosetron during hypermo-chemo-radiotherapy for esophageal cancer [ J ], Anticancer Res ,2000,20:3631 - 3636.
2Rabasseda X, Ramosertron A. 5-HT3 receptor antagonist for the control of nasea and vomiting [ J ]. Drug Today ( Bare ), 2002,38 (2) :75 -89.
3Kang YK, Park YH, Ryoo RY, et al. Ramosertron for the prevention of cisplatin-induced acute emesis: a prospective randomized comparison with granisctron [ J ]. J Int Med Res, 2002,30(3) :220 -229.
1Morita M,Kuwano H,Ohno S,et al. Antiemetic effect of ramosetron during hyperthermo-chemo-radiotherapy for esophageal cancer. Anticancer Res,2000,20:3631-3636.
2Ogata A,Yamada Y,Sugiura M,et al. Analysis of 5-HT3 receptor antagonist,ramosetron hydrochloride,based on receptor occupancy considering its active metabolite. Yakugaku Zasshi, 2001,121 :793-798
3Noda K,Ikeda M,Yoshida O,et al. Clinical phase III study of YM060 injection on anti-cancer drug-induced nausea and vomiting:double blind comparative study versus placebo. J Jpn Clin Exp Med,1994,71:2765-2776.
4Lwahashi M,Tanimura H. Nausea and emesis:drugs related to 5-HT3 and 5-HT4 receptor,such as azasetron、gransetron,ect. Med Drug J,2000,36:1407-1413.
5Noka K,Ikeda M,Yashida,O,et al. Clinical phase III study of YM060 Injection on anti-cancer drug,cisplatin-induced nausea and Vomiting. Med Cons New Remed,1994,43:2421-2255.
